These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19453946)

  • 1. Normal protein composition of synapses in Ts65Dn mice: a mouse model of Down syndrome.
    Fernandez F; Trinidad JC; Blank M; Feng DD; Burlingame AL; Garner CC
    J Neurochem; 2009 Jul; 110(1):157-69. PubMed ID: 19453946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.
    Pollonini G; Gao V; Rabe A; Palminiello S; Albertini G; Alberini CM
    Neuroscience; 2008 Sep; 156(1):99-106. PubMed ID: 18703118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficits in cognition and synaptic plasticity in a mouse model of Down syndrome ameliorated by GABAB receptor antagonists.
    Kleschevnikov AM; Belichenko PV; Faizi M; Jacobs LF; Htun K; Shamloo M; Mobley WC
    J Neurosci; 2012 Jul; 32(27):9217-27. PubMed ID: 22764230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Chronic Fluoxetine Treatment of Ts65Dn Mice Rescues Synaptic Vesicular Deficits and Prevents Aberrant Proteomic Alterations.
    Fatemi SH; Otte ED; Folsom TD; Eschenlauer AC; Roper RJ; Aman JW; Thuras PD
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome.
    Zorrilla de San Martin J; Donato C; Peixoto J; Aguirre A; Choudhary V; De Stasi AM; Lourenço J; Potier MC; Bacci A
    Elife; 2020 Aug; 9():. PubMed ID: 32783810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome.
    Belichenko PV; Kleschevnikov AM; Masliah E; Wu C; Takimoto-Kimura R; Salehi A; Mobley WC
    J Comp Neurol; 2009 Feb; 512(4):453-66. PubMed ID: 19034952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-Dependent Dysfunction in Visual and Olfactory Sensory Systems in Mouse Models of Down Syndrome.
    William CM; Saqran L; Stern MA; Chiang CL; Herrick SP; Rangwala A; Albers MW; Frosch MP; Hyman BT
    J Neurosci; 2017 Oct; 37(41):9880-9888. PubMed ID: 28899917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican.
    Howell MD; Gottschall PE
    ASN Neuro; 2012 Feb; 4(1):. PubMed ID: 22225533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nest building is impaired in the Ts65Dn mouse model of Down syndrome and rescued by blocking 5HT2a receptors.
    Heller HC; Salehi A; Chuluun B; Das D; Lin B; Moghadam S; Garner CC; Colas D
    Neurobiol Learn Mem; 2014 Dec; 116():162-71. PubMed ID: 25463650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From abnormal hippocampal synaptic plasticity in down syndrome mouse models to cognitive disability in down syndrome.
    Cramer N; Galdzicki Z
    Neural Plast; 2012; 2012():101542. PubMed ID: 22848844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome.
    Blanchard J; Bolognin S; Chohan MO; Rabe A; Iqbal K; Grundke-Iqbal I
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1070-9. PubMed ID: 22082658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current.
    Best TK; Siarey RJ; Galdzicki Z
    J Neurophysiol; 2007 Jan; 97(1):892-900. PubMed ID: 17093127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
    Faizi M; Bader PL; Tun C; Encarnacion A; Kleschevnikov A; Belichenko P; Saw N; Priestley M; Tsien RW; Mobley WC; Shamloo M
    Neurobiol Dis; 2011 Aug; 43(2):397-413. PubMed ID: 21527343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome.
    Nosheny RL; Belichenko PV; Busse BL; Weissmiller AM; Dang V; Das D; Fahimi A; Salehi A; Smith SJ; Mobley WC
    Neurobiol Dis; 2015 May; 77():173-90. PubMed ID: 25753471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome.
    Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
    J Neurosci; 2019 Jun; 39(26):5210-5221. PubMed ID: 31000585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.